Back to News
Market Impact: 0.35
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Source: 247wallst.com
Healthcare & BiotechMarket Technicals & Flows
Novavax shares fell 12% to $11.23 in afternoon trading, the steepest decline among vaccine developers as vaccine stocks came under heavy pressure. The article provides no specific catalyst for the selloff.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
NVAX-0.60
More News
- Palantir, Arm among market cap stock movers on Friday
- Why did CoreWeave stock get crushed this week? Look to this corner of the debt market for clues
- AI stock sell-off ramps up over debt-fueled data center spending fears: ‘Full-blown crisis of confidence'
- Stock fixing scandal could see Turkish companies frozen out of global indexes
- Dow falls 189 points as AI stocks slide and oil prices surge
- Wall Street's fear gauge is ripping. Traders see it going even higher
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Index and ETF Holdings Data for AI Research
- Capital Intensity as Gravity: The AI Trade Enters Its Industrial Era (Looking at Q3 2025 Earnings in Tech)